These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16856253)

  • 1. [Development trend of PET radiopharmaceuticals as post-FDG tumor imaging agents].
    Kawai K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Jun; 62(6):764-70. PubMed ID: 16856253
    [No Abstract]   [Full Text] [Related]  

  • 2. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production and delivery of F-18 FDG].
    Nakayama O
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Jun; 62(6):778-80. PubMed ID: 16856255
    [No Abstract]   [Full Text] [Related]  

  • 4. Beyond FDG: Many Molecular Imaging Agents Are in Development.
    Brower V
    J Natl Cancer Inst; 2011 Jan; 103(1):13-5. PubMed ID: 21169540
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
    Bailey DL
    J Nucl Med; 2010 Jan; 51(1):165-6; author reply 166-7. PubMed ID: 20008991
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.
    McConathy J; Yu W; Jarkas N; Seo W; Schuster DM; Goodman MM
    Med Res Rev; 2012 Jul; 32(4):868-905. PubMed ID: 21793016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG.
    Varagnolo L; Stokkel MP; Mazzi U; Pauwels EK
    Nucl Med Biol; 2000 Feb; 27(2):103-12. PubMed ID: 10773538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of 18F-FDG-PET in breast cancer imaging].
    Tayama K; Toh U; Fujii T; Shirouzu K; Kaida Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():373-8. PubMed ID: 17679209
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare image of a pulmonary nodule revealed on FDG-PET scans.
    Ichikawa M; Iwakami S; Fujii M; Takahashi K
    Intern Med; 2010; 49(20):2275-6. PubMed ID: 20962451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular imaging by PET/SPECT].
    Ono M
    Yakugaku Zasshi; 2009 Mar; 129(3):279-87. PubMed ID: 19252385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
    Basu S; Rao R
    J Nucl Med; 2010 Jan; 51(1):165; author reply 166-7. PubMed ID: 20008984
    [No Abstract]   [Full Text] [Related]  

  • 12. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
    Nguyen NC; Bhatla D; Osman MM
    J Nucl Med; 2010 Feb; 51(2):330-1; author reply 331. PubMed ID: 20080890
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron emission tomography radiotracers for imaging hypoxia.
    Wuest M; Wuest F
    J Labelled Comp Radiopharm; 2013; 56(3-4):244-50. PubMed ID: 24285331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
    Koga S; Nakano S; Honma Y; Ogasawara N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():379-84. PubMed ID: 17682181
    [No Abstract]   [Full Text] [Related]  

  • 15. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
    Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings in the Gerstmann-Sträussler-Scheinker syndrome in an 18F-FDG PET-CT study.
    Achury C; Camacho V; Fernández A; Gómez-Ansón B; Jaller R; Carrió I
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):352-3. PubMed ID: 23084018
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose.
    Shiue CY; Welch MJ
    Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics.
    Haubner R
    Radiother Oncol; 2010 Sep; 96(3):280-7. PubMed ID: 20724013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tracers beyond FDG in head and neck oncology.
    Gornik G; Weber W
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):529-40. PubMed ID: 22019710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technical Approaches for Quantitative Treatment Responses Using 18F-FDG PET].
    Miwa K; Miyaji N; Umeda T; Murata T; Wagatsuma K; Sasaki M
    Igaku Butsuri; 2015; 35(1):30-8. PubMed ID: 26753394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.